BioNxt Solutions (OTCMKTS:BNXTF) Stock Price Down 3.1% – Here’s What Happened

BioNxt Solutions Inc. (OTCMKTS:BNXTF) shares fell 3.1% during trading on Monday . The stock traded as low as $0.4365 and last traded at $0.4840. 3,961 shares traded hands during mid-day trading, a decline of 75% from the average session volume of 16,081 shares. The stock had previously closed at $0.4996.

BioNxt Solutions Price Performance

The company has a market capitalization of $56.03 million, a price-to-earnings ratio of -12.10 and a beta of 0.80. The firm has a fifty day simple moving average of $0.58 and a 200 day simple moving average of $0.52.

BioNxt Solutions (OTCMKTS:BNXTF) last announced its earnings results on Thursday, August 28th. The company reported ($0.01) earnings per share (EPS) for the quarter.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.